in the treatment of BPH? ini nth teh ter etraetmatemnetn otf o Bf PBHPH? ? in the treatment of BPH? Introduction Introduction

Introduction Stenting of the prostatic urethra was first described by Fabian in 1980, who used a stainless steel coil to treat patients who would otherwise have faced long-term catheterization.1 Initially, stents were designed for the temporary relief of bladder outflow obstruction secondary to benign prostatic hyperplasia (BPH). Their design was such that the stents did not become epithelialized and their use was associated with stent migration, recurrent infections and the development of encrustations on the stent.